JP2022519721A5 - - Google Patents
Info
- Publication number
- JP2022519721A5 JP2022519721A5 JP2021546285A JP2021546285A JP2022519721A5 JP 2022519721 A5 JP2022519721 A5 JP 2022519721A5 JP 2021546285 A JP2021546285 A JP 2021546285A JP 2021546285 A JP2021546285 A JP 2021546285A JP 2022519721 A5 JP2022519721 A5 JP 2022519721A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- hypnotic
- muscle relaxant
- nri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025016270A JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962803223P | 2019-02-08 | 2019-02-08 | |
| US62/803,223 | 2019-02-08 | ||
| PCT/US2020/017323 WO2020163785A1 (en) | 2019-02-08 | 2020-02-07 | Methods and compositions for treating sleep apnea |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025016270A Division JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519721A JP2022519721A (ja) | 2022-03-24 |
| JP2022519721A5 true JP2022519721A5 (enExample) | 2023-02-15 |
| JP7705348B2 JP7705348B2 (ja) | 2025-07-09 |
Family
ID=71947080
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546285A Active JP7705348B2 (ja) | 2019-02-08 | 2020-02-07 | 睡眠時無呼吸を治療するための方法および組成物 |
| JP2025016270A Pending JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025016270A Pending JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12558327B2 (enExample) |
| EP (2) | EP4635514A3 (enExample) |
| JP (2) | JP7705348B2 (enExample) |
| KR (2) | KR102980795B1 (enExample) |
| CN (2) | CN118557736A (enExample) |
| AU (2) | AU2020219809B2 (enExample) |
| BR (1) | BR112021015600A2 (enExample) |
| CA (1) | CA3129270A1 (enExample) |
| EA (1) | EA202192202A1 (enExample) |
| ES (1) | ES3049086T3 (enExample) |
| IL (1) | IL285197A (enExample) |
| MX (2) | MX2021009407A (enExample) |
| MY (1) | MY210043A (enExample) |
| PH (1) | PH12021551850A1 (enExample) |
| SG (1) | SG11202108225QA (enExample) |
| UA (1) | UA130366C2 (enExample) |
| WO (1) | WO2020163785A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111670050A (zh) | 2018-01-30 | 2020-09-15 | 爱普宁公司(特拉华) | 用于治疗睡眠呼吸暂停的方法和组合物 |
| ES3049086T3 (en) | 2019-02-08 | 2025-12-12 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| IL307186A (en) * | 2021-03-24 | 2023-11-01 | Apnimed Inc Delaware | Methods and preparations for treating sleep apnea |
| JP2024523876A (ja) * | 2021-06-17 | 2024-07-02 | アプニメッド，インコーポレイテッド（デラウェア） | 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤 |
| EP4522149A1 (en) * | 2022-05-13 | 2025-03-19 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
| CN119789855A (zh) * | 2022-09-02 | 2025-04-08 | 爱普宁公司(特拉华) | 治疗睡眠呼吸暂停的方法和组合物 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| AU767877B2 (en) | 1999-05-20 | 2003-11-27 | Sepracor, Inc. | Methods for treatment of asthma using S-oxybutynin |
| WO2001062236A2 (en) | 2000-02-24 | 2001-08-30 | Pharmacia & Upjohn Company | New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent |
| WO2002089843A1 (en) | 2001-03-13 | 2002-11-14 | Millenium Pharmaceuticals, Inc. | Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function |
| US20030185882A1 (en) | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
| US20040235925A1 (en) | 2002-12-17 | 2004-11-25 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
| CA2566154A1 (en) | 2004-05-27 | 2005-12-08 | Warner-Lambert Company Llc | Combination of atomoxetine and a 5t1a receptor agonist for treating adhd and other disorders |
| WO2006023703A2 (en) | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| US20060122127A1 (en) * | 2004-11-17 | 2006-06-08 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtzapine treatment |
| JP2008524332A (ja) | 2004-12-20 | 2008-07-10 | コレジウム ファーマシューティカル， インク． | 睡眠傷害のための医薬組成物 |
| FR2889811B1 (fr) * | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
| DK2083811T3 (en) | 2006-11-22 | 2017-01-30 | Clinical Res Ass Llc | PROCEDURES FOR TREATING DOWNS SYNDROME, FRAGILT X SYNDROME AND AUTISM |
| WO2008122019A1 (en) | 2007-04-02 | 2008-10-09 | Cypress Biosciences, Inc. | Improving the tolerability of both mirtazapine and reboxetine by using them in combination |
| AU2008236624A1 (en) * | 2007-04-09 | 2008-10-16 | Sepracor Inc. | Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| WO2008157094A1 (en) * | 2007-06-13 | 2008-12-24 | Cypress Bioscience, Inc. | Improving the tolerability of mirtazapine and a second active by using them in combination |
| BRPI0821761A2 (pt) * | 2007-12-21 | 2015-06-16 | Eurand Inc | Composições de comprimidos de desintegração oral de temazepam |
| US20100204058A1 (en) | 2009-01-28 | 2010-08-12 | Howard Yuan-Hao Chang | Profiling for Determination of Response to Treatment for Inflammatory Disease |
| CN107007602A (zh) | 2011-01-28 | 2017-08-04 | 辉达斯医学研究所 | 治疗阻塞性睡眠呼吸暂停的方法 |
| TWI621434B (zh) | 2014-10-24 | 2018-04-21 | 朗齊生物醫學股份有限公司 | 千憂解藥物應用於癌症治療 |
| HUE047169T2 (hu) | 2015-04-27 | 2020-04-28 | Arena Pharm Inc | 5-HT2C receptor agonisták és készítmények és felhasználási eljárások |
| JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
| ES2925951T3 (es) * | 2015-07-22 | 2022-10-20 | John Hsu | Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso |
| CN119185558A (zh) | 2017-04-28 | 2024-12-27 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
| CN111670050A (zh) | 2018-01-30 | 2020-09-15 | 爱普宁公司(特拉华) | 用于治疗睡眠呼吸暂停的方法和组合物 |
| ES3049086T3 (en) | 2019-02-08 | 2025-12-12 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
-
2020
- 2020-02-07 ES ES20752195T patent/ES3049086T3/es active Active
- 2020-02-07 EP EP25200289.4A patent/EP4635514A3/en active Pending
- 2020-02-07 CA CA3129270A patent/CA3129270A1/en active Pending
- 2020-02-07 CN CN202410525932.1A patent/CN118557736A/zh active Pending
- 2020-02-07 KR KR1020217027063A patent/KR102980795B1/ko active Active
- 2020-02-07 WO PCT/US2020/017323 patent/WO2020163785A1/en not_active Ceased
- 2020-02-07 MX MX2021009407A patent/MX2021009407A/es unknown
- 2020-02-07 US US17/428,596 patent/US12558327B2/en active Active
- 2020-02-07 EA EA202192202A patent/EA202192202A1/ru unknown
- 2020-02-07 CN CN202080026282.6A patent/CN113692277B/zh active Active
- 2020-02-07 PH PH1/2021/551850A patent/PH12021551850A1/en unknown
- 2020-02-07 SG SG11202108225QA patent/SG11202108225QA/en unknown
- 2020-02-07 EP EP20752195.6A patent/EP3920898B1/en active Active
- 2020-02-07 MY MYPI2021004502A patent/MY210043A/en unknown
- 2020-02-07 JP JP2021546285A patent/JP7705348B2/ja active Active
- 2020-02-07 UA UAA202104441A patent/UA130366C2/uk unknown
- 2020-02-07 BR BR112021015600-3A patent/BR112021015600A2/pt unknown
- 2020-02-07 KR KR1020267019432A patent/KR20260103155A/ko active Pending
- 2020-02-07 AU AU2020219809A patent/AU2020219809B2/en active Active
-
2021
- 2021-07-28 IL IL285197A patent/IL285197A/en unknown
- 2021-08-04 MX MX2025004365A patent/MX2025004365A/es unknown
-
2025
- 2025-02-03 JP JP2025016270A patent/JP2025084754A/ja active Pending
- 2025-07-15 AU AU2025205464A patent/AU2025205464A1/en active Pending
-
2026
- 2026-01-23 US US19/457,930 patent/US20260151361A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2148670B1 (en) | Titration of tapentadol | |
| CA2914365C (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| US20250177385A1 (en) | Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder | |
| JP5241228B2 (ja) | 非ステロイド性抗炎症薬、鬱血除去薬および鎮静作用の少ない抗ヒスタミン薬を含む多層錠 | |
| JP2025084754A5 (enExample) | ||
| CN104379138B (zh) | 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合 | |
| US20090023744A1 (en) | Combination therapy for depression | |
| CN106413717A (zh) | 药物组合物 | |
| JP2008524332A (ja) | 睡眠傷害のための医薬組成物 | |
| CA2929909C (en) | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome | |
| TW202317101A (zh) | 治療抑鬱狀態之方法 | |
| JP2020533415A (ja) | ナルコレプシーの処置におけるガボキサドールの使用 | |
| JP2022506113A5 (enExample) | ||
| US20090035370A1 (en) | Dosage form and method of use | |
| TW202228660A (zh) | 經口投予製劑 | |
| HK1233916A1 (en) | Titration of tapentadol | |
| HK1140940B (en) | Titration of tapentadol | |
| HK40081197A (en) | Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder |